Surgery Partners (SGRY)
(Delayed Data from NSDQ)
$24.55 USD
-0.29 (-1.17%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $24.53 -0.02 (-0.08%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Balance Sheet
Fiscal Year End for Surgery Partners, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 196 | 283 | 390 | 318 | 93 |
Receivables | 496 | 456 | 430 | 382 | 327 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 75 | 71 | 61 | 56 | 46 |
Other Current Assets | 128 | 110 | 65 | 45 | 60 |
Total Current Assets | 895 | 921 | 946 | 802 | 526 |
Net Property & Equipment | 969 | 877 | 630 | 545 | 523 |
Investments & Advances | 184 | 190 | 89 | 90 | 93 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 90 | 92 | 114 | 125 | 99 |
Intangibles | 4,381 | 4,179 | 3,956 | 3,515 | 3,450 |
Deposits & Other Assets | 103 | 144 | 59 | 27 | 329 |
Total Assets | 6,877 | 6,682 | 6,118 | 5,413 | 5,019 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 172 | 152 | 125 | 100 | 97 |
Current Portion Long-Term Debt | 73 | 63 | 60 | 64 | 56 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 74 | 72 | 142 | 175 | 54 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 204 | 207 | 210 | 217 | 191 |
Total Current Liabilities | 523 | 493 | 537 | 557 | 398 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,702 | 2,559 | 2,878 | 2,792 | 2,525 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 41 | 75 | 87 | 140 | 397 |
Minority Interest (Liabilities) | 327 | 342 | 330 | 307 | 321 |
Total Liabilities | 3,842 | 3,741 | 4,148 | 4,097 | 3,641 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 435 | 395 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 2,498 | 2,478 | 1,622 | 608 | 663 |
Retained Earnings | -569 | -557 | -503 | -432 | -316 |
Other Equity | 1,105 | 1,019 | 849 | 706 | 636 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 3,035 | 2,941 | 1,970 | 1,317 | 1,378 |
Total Liabilities & Shareholder's Equity | 6,877 | 6,682 | 6,118 | 5,413 | 5,019 |
Total Common Equity | 3,035 | 2,941 | 1,970 | 882 | 983 |
Shares Outstanding | 126.40 | 125.90 | 89.30 | 50.40 | 50.00 |
Book Value Per Share | 24.01 | 23.36 | 22.06 | 17.50 | 19.67 |
Fiscal Year End for Surgery Partners, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 196 | 236 | 177 | 246 |
Receivables | NA | 496 | 463 | 450 | 453 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 75 | 69 | 70 | 72 |
Other Current Assets | NA | 128 | 108 | 113 | 99 |
Total Current Assets | NA | 895 | 876 | 810 | 869 |
Net Property & Equipment | NA | 969 | 940 | 826 | 844 |
Investments & Advances | NA | 184 | 196 | 192 | 192 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 90 | 105 | 106 | 93 |
Intangibles | NA | 4,381 | 4,301 | 4,291 | 4,253 |
Deposits & Other Assets | NA | 103 | 117 | 128 | 119 |
Total Assets | NA | 6,877 | 6,780 | 6,621 | 6,643 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 172 | 149 | 132 | 144 |
Current Portion Long-Term Debt | NA | 73 | 62 | 65 | 63 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 74 | 82 | 64 | 68 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 204 | 208 | 198 | 200 |
Total Current Liabilities | NA | 523 | 501 | 459 | 475 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 2,702 | 2,640 | 2,505 | 2,531 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 79 | 82 | 80 | |
Minority Interest (Liabilities) | NA | 327 | 332 | 328 | 346 |
Total Liabilities | NA | 3,842 | 3,794 | 3,638 | 3,701 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 1 | 1 | 1 | 1 |
Capital Surplus | NA | 2,498 | 2,495 | 2,501 | 2,478 |
Retained Earnings | NA | -569 | -568 | -563 | -582 |
Other Equity | NA | 1,105 | 1,059 | 1,043 | 1,045 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 3,035 | 2,987 | 2,983 | 2,943 |
Total Liabilities & Shareholder's Equity | NA | 6,877 | 6,780 | 6,621 | 6,643 |
Total Common Equity | 0 | 3,035 | 2,987 | 2,983 | 2,943 |
Shares Outstanding | 126.60 | 126.40 | 126.50 | 126.50 | 126.40 |
Book Value Per Share | 0.00 | 24.01 | 23.61 | 23.58 | 23.28 |